These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 27461775)

  • 21. Patterns of failure in limited-stage small cell lung cancer: Implications of TNM stage for prophylactic cranial irradiation.
    Wu AJ; Gillis A; Foster A; Woo K; Zhang Z; Gelblum DY; Downey RJ; Rosenzweig KE; Ong L; Perez CA; Pietanza MC; Krug L; Rudin CM; Rimner A
    Radiother Oncol; 2017 Oct; 125(1):130-135. PubMed ID: 28778345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of prophylactic cranial irradiation in limited-stage small-cell lung cancer: which patients could benefit?
    Kou P; Wang H; Yang D; Zhang Y; Yu J
    Future Oncol; 2019 Jan; 15(1):3237-3245. PubMed ID: 30091368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the use of prophylactic cranial irradiation in small cell lung cancer.
    Patel S; Macdonald OK; Suntharalingam M
    Cancer; 2009 Feb; 115(4):842-50. PubMed ID: 19117355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of PET staging in limited-stage small-cell lung cancer.
    Xanthopoulos EP; Corradetti MN; Mitra N; Fernandes AT; Kim M; Grover S; Christodouleas JP; Evans TL; Stevenson JP; Langer CJ; Lee TT; Pryma DA; Lin LL; Simone CB; Apisarnthanarax S; Rengan R
    J Thorac Oncol; 2013 Jul; 8(7):899-905. PubMed ID: 23608814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prophylactic Cranial Irradiation for Patients with Surgically Resected Small Cell Lung Cancer.
    Xu J; Yang H; Fu X; Jin B; Lou Y; Zhang Y; Zhang X; Zhong H; Wang H; Wu D; Han B
    J Thorac Oncol; 2017 Feb; 12(2):347-353. PubMed ID: 27725211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prophylactic Cranial Irradiation for Limited-Stage Small-Cell Lung Cancer Patients: Secondary Findings From the Prospective Randomized Phase 3 CONVERT Trial.
    Levy A; Le Péchoux C; Mistry H; Martel-Lafay I; Bezjak A; Lerouge D; Padovani L; Taylor P; Faivre-Finn C
    J Thorac Oncol; 2019 Feb; 14(2):294-297. PubMed ID: 30292850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Total gross tumor volume is an independent prognostic factor in patients treated with selective nodal irradiation for stage I to III small cell lung cancer.
    Reymen B; Van Loon J; van Baardwijk A; Wanders R; Borger J; Dingemans AM; Bootsma G; Pitz C; Lunde R; Geraedts W; Lambin P; De Ruysscher D
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1319-24. PubMed ID: 23200174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usage of Prophylactic Cranial Irradiation in Elderly Patients With Small-cell Lung Cancer.
    Damhuis RAM; Senan S; Belderbos JS
    Clin Lung Cancer; 2018 Mar; 19(2):e263-e267. PubMed ID: 29208355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylactic Cranial Irradiation for Limited-Stage Small-Cell Lung Cancer: Survey of US Radiation Oncologists on Current Practice Patterns.
    Farrell MJ; Yahya JB; Degnin C; Chen Y; Holland JM; Henderson MA; Jaboin JJ; Harkenrider MM; Thomas CR; Mitin T
    Clin Lung Cancer; 2018 Jul; 19(4):371-376. PubMed ID: 29559208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylactic cranial irradiation in limited-stage small-cell lung cancer: a retrospective analysis.
    Alshehadat S; Sahmoun AE
    Clin Adv Hematol Oncol; 2004 Jun; 2(6):397-400. PubMed ID: 16163213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of Prophylactic Cranial Irradiation According to the Risk of Extracranial Recurrence in Limited-Stage Small Cell Lung Cancer.
    Lee TH; Chung JH; Wu HG; Kim S; Lee JH; Keam B; Kim JS; Kim KH; Kim BH; Kim HJ
    Cancer Res Treat; 2023 Jul; 55(3):875-884. PubMed ID: 36915254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors affecting the risk of brain metastasis in small cell lung cancer with surgery: is prophylactic cranial irradiation necessary for stage I-III disease?
    Gong L; Wang QI; Zhao L; Yuan Z; Li R; Wang P
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):196-200. PubMed ID: 22818415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Should patients with extrapulmonary small-cell carcinoma receive prophylactic cranial irradiation?
    Naidoo J; Teo MY; Deady S; Comber H; Calvert P
    J Thorac Oncol; 2013 Sep; 8(9):1215-21. PubMed ID: 23945390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small Cell Lung Cancer.
    Kalemkerian GP
    Semin Respir Crit Care Med; 2016 Oct; 37(5):783-796. PubMed ID: 27732999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prophylactic cranial irradiation for limited-stage small-cell lung cancer in the magnetic resonance imaging era.
    Pan L; Fan X; Wang L; Wang Y; Li Y; Cui Y; Zheng H; Yi Q; Wu K
    Cancer Med; 2023 Feb; 12(3):2484-2492. PubMed ID: 35894822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prophylactic Cranial Irradiation in Extensive Stage Small Cell Lung Cancer: Outcomes at a Comprehensive Cancer Centre.
    Bang A; Kendal WS; Laurie SA; Cook G; MacRae RM
    Int J Radiat Oncol Biol Phys; 2018 Aug; 101(5):1133-1140. PubMed ID: 29908788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes of prophylactic cranial irradiation in patients with small cell lung cancer in the modern era of baseline magnetic resonance imaging of the brain.
    Held MK; Hansen O; Schytte T; Hansen KH; Bahij R; Nielsen M; Nielsen TB; Jeppesen SS
    Acta Oncol; 2022 Feb; 61(2):185-192. PubMed ID: 34583620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival benefit of prophylactic cranial irradiation in limited-stage small-cell lung cancer in modern magnetic resonance imaging staging: a systematic review and meta-analysis.
    Liu J; Shen B; Yang Y; Guo J; Ren W; Zhou Q; Mao J; Ye W; Wu D
    Acta Oncol; 2023 Mar; 62(3):305-314. PubMed ID: 37010509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prophylactic cranial irradiation for patients with small-cell lung cancer: a systematic review of the literature with meta-analysis.
    Zhang W; Jiang W; Luan L; Wang L; Zheng X; Wang G
    BMC Cancer; 2014 Oct; 14():793. PubMed ID: 25361811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of outcome prediction and disease extension by quantitative 2-deoxy-2-[18F] fluoro-D-glucose with positron emission tomography in patients with small cell lung cancer.
    Arslan N; Tuncel M; Kuzhan O; Alagoz E; Budakoglu B; Ozet A; Ozguven MA
    Ann Nucl Med; 2011 Jul; 25(6):406-13. PubMed ID: 21409347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.